Originally used for type 2 diabetes, these therapies are now approved for weight management
For example, in a prospective study aimed at investigating the influence of GLP-1RA and DPP4 inhibitors on the development of depression in patients with newly diagnosed T2DM, participants receiving incretin-based therapies displayed marked reduction of depressive symptoms after one year, when compared to the control group
Use this handy guide of questions to ask before starting a GLP-1
Front Endocrinol (Lausanne) (2018) 9:672
Better sleep and cognitive clarity: GH-stimulating peptides improve slow-wave sleep quality, which in turn supports testosterone production, memory consolidation, and mental sharpness
Visit FDA MedWatch at www.fda.gov/medwatch or call 1800FDA1088 .